Skip to main content
International
Ask us anything:
  • About
        • About We challenge convention so healthy can be possible for all
        • Our Story
          • Amneal at-a-glance
          • Our Founders
        • Our Purpose & Commitments
        • Our Culture
          • Learn, Lead, Succeed
          • Our Culture in Action
        • Our Milestones
        • Leadership
          • Executive Leadership
          • Board of Directors
        • Locations
        • Responsibility
          • Patient Assistance Programs
          • Product Donations
          • National & Local Philanthropy
          • Compliance and Ethics
        • Awards & Recognition
        • Amneal About
  • Products
        • Products We produce quality generic, specialty and biosimilar medicines
        • Our Portfolio
          • Generic Products
          • Specialty Products
          • Product Catalog
        • Quality
        • Drug Safety
          • Adverse Event Reporting
          • Medical Inquiries
          • Product Complaints
        • Operations
        • Amneal Products
  • Research & Development
        • Research & Development We invest significantly in new product development
        • Generics R&D
        • Specialty R&D
        • Product Partnering
        • Amneal Research and Technology
  • Investors
        • Investors Become an Informed Investor
        • Amneal Investors
  • News
  • Careers
        • Careers Join our quest to make healthy possible
        • Total Rewards
        • Search Our Career Opportunities
        • Amneal Careers
  • Contact
  • Customer Login
Amneal Pharmaceuticals
  • Investor Relations
  • Financial Reports
    • SEC Filings
    • Annual Reports
    • Quarterly & Other Reports
  • Events & Presentations
  • Stock Information
  • Corporate Governance
    • Policies
    • Executive Officers & Directors
    • Board Committees
  • Investor Resources
    • Analysts
    • Investor FAQ
    • Email Alerts
    • Information Request
    • RSS Feeds

Home Home  >  News  >  Press Releases  >  Press Release Details

  • Investor Relations
  • Financial Reports
    • SEC Filings
    • Annual Reports
    • Quarterly & Other Reports
  • Events & Presentations
  • Stock Information
  • Corporate Governance
    • Policies
    • Executive Officers & Directors
    • Board Committees
  • Investor Resources
    • Analysts
    • Investor FAQ
    • Email Alerts
    • Information Request
    • RSS Feeds
View all Press Releases

Amneal Closes Purchase of Interpharm Assets

June 28, 2008
Download this Press Release PDF Format (opens in new window) (PDF 55 KB)
View all Press Releases

Investor Faq

Get answers to important investor relation questions.

More

Investor Tools

  • Email Alerts
  • RSS Feeds
  • Email Page

IR Contact

Get answers to your investor relation questions.

More
  • Privacy Policy
  • Copyright & Legal Disclaimer
  • Web Accessibility
© Amneal Pharmaceuticals LLC.
All rights reserved.
Powered By Q4 Inc. 5.52.0.6 (opens in new window)
Back to top